{
  "prompt": {
    "guidelineId": "cg1198-management-of-hypertensive-disorders-of-pregnancy-pdf",
    "fieldsProcessed": [
      "humanFriendlyName",
      "organisation",
      "yearProduced",
      "summary"
    ],
    "enhancedFields": 4,
    "contentLength": 3503
  },
  "response": "{\n  \"success\": true,\n  \"enhancedFields\": [\n    {\n      \"field\": \"humanFriendlyName\",\n      \"oldValue\": null,\n      \"newValue\": \"Hypertensive Disorders of Pregnancy: Care Guidelines\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"organisation\",\n      \"oldValue\": null,\n      \"newValue\": \"RCOG\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"yearProduced\",\n      \"oldValue\": null,\n      \"newValue\": \"The given text does not contain a publication year. If you have another guideline text that includes the year, please provide it, and I can extract the 4-digit year for you\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"summary\",\n      \"oldValue\": null,\n      \"newValue\": \"**Summary of Hypertensive Disorders of Pregnancy Guideline** **Definitions:** - **Chronic hypertension:** Present before 20 weeks. - **Gestational hypertension:** New hypertension after 20 weeks without significant proteinuria. - **Pre-eclampsia:** New hypertension after 20 weeks with significant proteinuria. - **Severe pre-eclampsia/Eclampsia/HELLP syndrome:** Life-threatening complications. **Assessment:** - Hypertension: ≥140/90 mmHg (severe if ≥160/110). - Proteinuria: Use reagent-strip device; quantify via protein:creatinine ratio. **Risk Factors:** - **Moderate:** Age ≥40, nulliparity, BMI ≥35, family history. - **High:** Chronic hypertension, prior pre-eclampsia, diabetes, kidney/autoimmune disease. **Management:** - **High-risk women:** Monitor BP/urinalysis every 2 weeks from 28 weeks; consider uterine artery Dopplers/ultrasounds. - **Chronic hypertension:** Target BP ≤135/85; use Labetalol, Nifedipine, or Methyldopa. Avoid harmful medications. - **Gestational hypertension:** Monitor BP; treat pharmacologically if needed. Avoid delivery <37 weeks unless severe. - **Pre-eclampsia:** First-line Labetalol; monitor BP/fetal wellbeing. Plan delivery based on severity/gestational age. **Postnatal Care:** - Continue BP monitoring; review with GP/obstetrician. Recurrence risk: ~20% in future pregnancies. **Key Symptoms:** Severe headache, vision changes, rib pain, vomiting, sudden swelling—prompt BP/urinalysis check\",\n      \"action\": \"added\"\n    }\n  ]\n}",
  "endpoint": "enhanceGuidelineMetadata",
  "timestamp": "2025-06-18T22-03-23",
  "textContent": "AI: DeepSeek (deepseek-chat)\n\nQ: {\n  \"guidelineId\": \"cg1198-management-of-hypertensive-disorders-of-pregnancy-pdf\",\n  \"fieldsProcessed\": [\n    \"humanFriendlyName\",\n    \"organisation\",\n    \"yearProduced\",\n    \"summary\"\n  ],\n  \"enhancedFields\": 4,\n  \"contentLength\": 3503\n}\n\nA: {\n  \"success\": true,\n  \"enhancedFields\": [\n    {\n      \"field\": \"humanFriendlyName\",\n      \"oldValue\": null,\n      \"newValue\": \"Hypertensive Disorders of Pregnancy: Care Guidelines\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"organisation\",\n      \"oldValue\": null,\n      \"newValue\": \"RCOG\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"yearProduced\",\n      \"oldValue\": null,\n      \"newValue\": \"The given text does not contain a publication year. If you have another guideline text that includes the year, please provide it, and I can extract the 4-digit year for you\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"summary\",\n      \"oldValue\": null,\n      \"newValue\": \"**Summary of Hypertensive Disorders of Pregnancy Guideline** **Definitions:** - **Chronic hypertension:** Present before 20 weeks. - **Gestational hypertension:** New hypertension after 20 weeks without significant proteinuria. - **Pre-eclampsia:** New hypertension after 20 weeks with significant proteinuria. - **Severe pre-eclampsia/Eclampsia/HELLP syndrome:** Life-threatening complications. **Assessment:** - Hypertension: ≥140/90 mmHg (severe if ≥160/110). - Proteinuria: Use reagent-strip device; quantify via protein:creatinine ratio. **Risk Factors:** - **Moderate:** Age ≥40, nulliparity, BMI ≥35, family history. - **High:** Chronic hypertension, prior pre-eclampsia, diabetes, kidney/autoimmune disease. **Management:** - **High-risk women:** Monitor BP/urinalysis every 2 weeks from 28 weeks; consider uterine artery Dopplers/ultrasounds. - **Chronic hypertension:** Target BP ≤135/85; use Labetalol, Nifedipine, or Methyldopa. Avoid harmful medications. - **Gestational hypertension:** Monitor BP; treat pharmacologically if needed. Avoid delivery <37 weeks unless severe. - **Pre-eclampsia:** First-line Labetalol; monitor BP/fetal wellbeing. Plan delivery based on severity/gestational age. **Postnatal Care:** - Continue BP monitoring; review with GP/obstetrician. Recurrence risk: ~20% in future pregnancies. **Key Symptoms:** Severe headache, vision changes, rib pain, vomiting, sudden swelling—prompt BP/urinalysis check\",\n      \"action\": \"added\"\n    }\n  ]\n}",
  "ai_provider": "DeepSeek",
  "ai_model": "deepseek-chat",
  "token_usage": null
}